Skin Health & Anti-Wrinkle — Peptide Research Overview

Relevant Compounds

• GHK-Cu — Copper tripeptide with well-documented collagen synthesis promotion, anti-inflammatory effects, and gene expression modulation in aging skin.
• Matrixyl (Palmitoyl Pentapeptide-4) — Synthetic signal peptide that upregulates collagen I, III, fibronectin, and hyaluronic acid synthesis in dermal fibroblasts.

What the Research Shows

GHK-Cu

[Human Trial / In Vitro] GHK-Cu has been studied in clinical settings for wound healing and skin rejuvenation. Human studies using topical GHK-Cu creams show statistically significant improvements in skin density, firmness, wrinkle depth, and photodamage over 12-week periods. In vitro, GHK-Cu modulates approximately 4,000 genes — including upregulation of antioxidant, anti-inflammatory, and collagen synthesis pathways while downregulating senescence-associated pathways. Systemic IV and subcutaneous use is an emerging research area.

Matrixyl

[Human Trial / In Vitro] The original Matrixyl (palmitoyl pentapeptide-4, formerly pal-KTTKS) and Matrixyl 3000 (combination of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7) have been the subject of independent clinical studies. A double-blind RCT published in the International Journal of Cosmetic Science showed significant wrinkle volume reduction vs. placebo at 8 weeks. The mechanism involves stimulating TGF-beta receptor activity in fibroblasts to upregulate collagen matrix proteins.

Evidence Summary